SE0000303D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE0000303D0
SE0000303D0 SE0000303A SE0000303A SE0000303D0 SE 0000303 D0 SE0000303 D0 SE 0000303D0 SE 0000303 A SE0000303 A SE 0000303A SE 0000303 A SE0000303 A SE 0000303A SE 0000303 D0 SE0000303 D0 SE 0000303D0
Authority
SE
Sweden
Prior art keywords
compounds
combinations
novel compounds
medicament
manufacture
Prior art date
Application number
SE0000303A
Other languages
English (en)
Inventor
Mattias Belting
Niklas Falk
Lars-Aake Fransson
Goeran Magnusson
Katrin Mani
Original Assignee
Xylogen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xylogen Ab filed Critical Xylogen Ab
Priority to SE0000303A priority Critical patent/SE0000303D0/sv
Publication of SE0000303D0 publication Critical patent/SE0000303D0/sv
Priority to US10/182,135 priority patent/US20030092637A1/en
Priority to CA002398643A priority patent/CA2398643A1/en
Priority to PCT/SE2001/000167 priority patent/WO2001054702A1/en
Priority to JP2001554686A priority patent/JP2003520819A/ja
Priority to EP01902926A priority patent/EP1251859A1/en
Priority to AU2001230689A priority patent/AU2001230689A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
SE0000303A 2000-01-31 2000-01-31 Novel compounds SE0000303D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE0000303A SE0000303D0 (sv) 2000-01-31 2000-01-31 Novel compounds
US10/182,135 US20030092637A1 (en) 2000-01-31 2001-01-30 Novel compounds
CA002398643A CA2398643A1 (en) 2000-01-31 2001-01-30 Novel compounds
PCT/SE2001/000167 WO2001054702A1 (en) 2000-01-31 2001-01-30 Novel compounds
JP2001554686A JP2003520819A (ja) 2000-01-31 2001-01-30 新規な化合物
EP01902926A EP1251859A1 (en) 2000-01-31 2001-01-30 Novel compounds
AU2001230689A AU2001230689A1 (en) 2000-01-31 2001-01-31 Novel compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0000303A SE0000303D0 (sv) 2000-01-31 2000-01-31 Novel compounds

Publications (1)

Publication Number Publication Date
SE0000303D0 true SE0000303D0 (sv) 2000-01-31

Family

ID=20278290

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0000303A SE0000303D0 (sv) 2000-01-31 2000-01-31 Novel compounds

Country Status (7)

Country Link
US (1) US20030092637A1 (sv)
EP (1) EP1251859A1 (sv)
JP (1) JP2003520819A (sv)
AU (1) AU2001230689A1 (sv)
CA (1) CA2398643A1 (sv)
SE (1) SE0000303D0 (sv)
WO (1) WO2001054702A1 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02010551A (es) * 2000-04-26 2003-09-25 Univ Kingston Formulaciones y metodos de uso de mimeticos del oxido nitrico contra fenotipos de celulas malignas.
US20050142217A1 (en) * 2000-04-26 2005-06-30 Adams Michael A. Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
US7678391B2 (en) * 2000-04-26 2010-03-16 Queen's University At Kingston Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
IL152397A (en) * 2002-10-21 2009-02-11 Hadasit Med Res Service Compositions and compounds for the treatment of hyperglycemia
SE0401871D0 (sv) * 2004-07-15 2004-07-15 Glucogene Medical Hfm Ab New compositions
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20150328245A1 (en) * 2012-12-18 2015-11-19 Godavari Biorefineries Limited Agents for Eliminating Tumour-Initiating Cells
CN107405404A (zh) * 2015-03-20 2017-11-28 塞米·欧尤·奥皮约 苏拉明和精氨酸酶抑制剂在恶性肿瘤中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3172379D1 (en) * 1980-12-09 1985-10-24 Seikagaku Kogyo Co Ltd D-xylopyranoside series compounds and therapeutical compositions containing same
US5104856A (en) * 1990-11-09 1992-04-14 Uab Research Foundation Heparan sulfate biosynthesis primers
JP3514493B2 (ja) * 1993-09-20 2004-03-31 生化学工業株式会社 Ｓ−β−Ｄ−キシロピラノシド系化合物

Also Published As

Publication number Publication date
CA2398643A1 (en) 2001-08-02
JP2003520819A (ja) 2003-07-08
EP1251859A1 (en) 2002-10-30
AU2001230689A1 (en) 2001-08-07
US20030092637A1 (en) 2003-05-15
WO2001054702A1 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
SE0001899D0 (sv) New compounds
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
TW200510375A (en) New compounds
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
PT1119543E (pt) N-aralquilaminotetralinas como ligandos para o receptor y5 do neuropeptido y
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
WO2004030611A3 (en) Non-nucleoside reverse transcriptase inhibitors
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
WO2003009838A1 (fr) Utilisation de composes de stilbene dans la preparation de medicaments pour le traitement ou la prevention du diabete et des maladies associees au retrovirus
SE9900961D0 (sv) Novel compounds
SE9802208D0 (sv) Novel compounds
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen
SE0102440D0 (sv) New compound
CL2009000980A1 (es) Uso de (s)-n-(2-(1,6,8-tetrahidro-2h-inden[5,4-b]furan-8-il)etil]propionamida en combinacion con una o más drogas seleccionadas de un grupo definido para preparar un medicamento útil para la prevencion o tratamiento de la depresión o desórdenes de ansiedad (divisional de la solicitud 749-2006).
SE0000303D0 (sv) Novel compounds
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
SE9802209D0 (sv) Novel compounds
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
SE0302924D0 (sv) Pharmaceutical composition having a cationic excipient
SE0203817D0 (sv) New composition